Business Growth Strategy

  • Increase Market Share in Canada. We intend to expand our market share in Canada through strategic acquisitions of additional multidisciplinary primary health care providers and clinics in markets that we currently populate, as well as in new geographic markets. In addition, we expect to continue increasing our market share in existing eldercare services, occupational therapy services, physiotherapy services and speech language pathology services through network affiliation growth and new contract awards.

  • Launch our Exclusive Cannabidiol ("CBD") Medical Cannabis Product Platform in Canada. Our platform is expected to include CBD manufacturing, sales and distribution. We expect that our CBD products will be specifically focused on CBD for use (i) as a treatment aid; (ii) to provide relief for a large array of neurological and musculoskeletal system disorders; and (iii) as an alternative option for health care providers in place of prescribing opioids to patients. Offering our patients access to non-hallucinogenic and non-addictive natural remedies, under required clinical oversight policies and procedures as they relate to medicinal cannabis and CBD, combined with our existing clinic-based treatment protocols allows us to enter this market segment with a unique integration model not readily available in the marketplace.

  • Build an Intellectual Property Portfolio. We intend to procure, create or pursue licensing rights for Intellectual Property (IP) and patents related to health sciences and nano-formulation. When considering nano-formulation IP, one specific area we intend to pursue relates to medical cannabis related medicines, beverages and foods infused with dry powder, liquid or oil with further formulation into creams and gels, allowing for oral, intravenous and/or transdermal delivery.

  • Expand Operations into the United States. We plan to expand operations into the U.S. through:

    • The introduction of a customized version of our multidisciplinary primary health care service model, with emphasis on pain prevention, treatment and management,
    • The strategic acquisition of targeted U.S. operating clinics in key geographical areas,
    • Establishment of strategic corporate alliances and partnerships with existing U.S. health care provider facilities, including certain of our current Canadian clients with U.S.-based facilities, allowing us immediate access to their client base; and
    • Integration of specific specialized multidisciplinary primary health care services and products that are a direct compliment to the existing primary care related products and services already provided by brand-recognized, established retail entities such as grocers, pharmacies, health fitness clinics and clinics.

  • Expand LA Fitness U.S. and LA Fitness Canada Master Facility License Agreement. Under the terms of our Agreement with LA Fitness, we will develop, open for business and operate, either through a third-party sublicense or corporate sponsored arrangement, facilities within LA Fitness U.S. and LA Fitness Canada locations which will provide outpatient physical and occupational therapy services.

  • Introduction of "Micro-clinics" in Certain Underserved Population Clinics. We plan to leverage our expertise in the interface of technology and patient engagement to introduce our multidisciplinary primary health care services and products through "micro-clinics" located in certain underserved population clinics. Rather than relying on the traditional centralized model of bringing people to health care, our "micro-clinic" model allows for people in urban, rural and remote population clinics to have greater access and availability to a wide range of health care products and services.

  • Develop our Remote Patient Monitoring (RPM) platform in Canada and the United States. RPM provides clinicians and practitioners the ability to maintain an on-going continuous connection with their patient community, beyond the traditional confines of a clinic, extending oversight of patient care and monitoring directly into the patient's home. Through our recently executed exclusive licensing agreement with Cloud Dx, Inc. we are expanding our offering of RPM technology to not only our Canadian clinics and affiliate clinics but to clinics throughout Canada and the United States.

  • Develop our Virtual Physician Access System Platform (Telemedicine). We continue the development of our virtual physician access system, sometimes referred to in the industry as "telemedicine" or "virtual medicine." Our telemedicine system intends to provide patients with real-time access to third-party primary care medically licensed physicians and specialists in various medical disciplines, in addition to providing access to multidisciplinary primary health care clinicians. Telemedicine is transforming traditional approaches to health care by providing ease of access and reduced costs for patients, particularly in areas with limited access to primary care licensed general practitioners and specialists. Our advanced telemedicine platform intends to integrate certain medical devices, such as a blood pressure reading device, a derma scope and an ophthalmoscope otoscope, each of which can provide the doctor with real-time diagnostic data, greatly enhancing the doctor's ability to provide the patient with an accurate diagnosis. Our telemedicine platform is intended to allow any health care clinic or location to install and utilize our telemedicine platform at a relatively low-cost point of entry.

  • Acquire Ownership Interest in Licensed Pharmaceutical Manufacturing and Packaging Facilities. As we build our Intellectual Property portfolio, having ownership of a licensed high-grade pharmaceutical product manufacturing and packaging solution is integral in creating the medium for use and application of our proprietary sciences as well as mitigating market exclusion and enhancing patient services and product offerings.

  • Expand our Posture, Stride, and Kinetic Body Movement Scanning Technologies and Protocols. When combined with decades of data harvesting and analysis, we believe these specialized technologies and protocols provide our clinics with the ability to deliver better care, early diagnosis and preventative health care strategies.